All Clinical Trials

NCT05620823

e.g. Massachusetts•Healthy volunteers: No

Results: 1

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Quebec, Phoenix, Arkansas, Fort Smithshow 39 more

Code:

NCT05620823

Conditions

Hidradenitis Suppurativa (HS)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

NCT05620823

e.g. Massachusetts•Healthy volunteers: No

Results: 1

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Quebec, Phoenix, Arkansas, Fort Smithshow 39 more

Code:

NCT05620823

Conditions

Hidradenitis Suppurativa (HS)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo